Surface-enhanced Raman spectroscopy (SERS)-vertical flow assays have shown promise for the multiplex detection of exosome proteins (Mucin short variant S1 (MUC1), HER2, and CEA) which are useful for identifying breast cancer subtypes. Here, ERBB2 is linked to breast cancer.